Wen Li

3.4k citations
123 papers · 2.1k indexed · 1 hit paper · h-index 25

Wen Li

112 papers receiving 2.1k citations

Hit Papers

Scutellarin ameliorates pulmonary fibrosis through inhibi...268202020262022202450100150200250

Peers

Wen Li
Comparison fields: 5 of 133
  • Structural Biology 32
  • Pharmacology 161
  • Cancer Research 263
  • Molecular Biology 1.0k
  • Pulmonary and Respiratory Medicine 409
Replace Ola Hammarsten with:
Ola Hammarsten Sweden
Fulong Liao China
Rong Fan China
Chen Wang China
Lara Gibellini Italy
Steven C. Borkan United States
Rafał Jakub Bułdak Poland
Koichi Uemura Japan
Lobelia Samavati United States
Meng Gao China
Wen Li relative to Ola Hammarsten Sweden Ola Hammarsten's profile →
Citations per field
00.5×6.7×
Ola Hammarsten · 1×
Citations per year

Countries citing papers authored by Wen Li

Since Specialization
Citations

This map shows the geographic impact of Wen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Li more than expected).

Fields of papers citing papers by Wen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Li. The network helps show where Wen Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wen Li Line = papers co-authored together Wen Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20243
4 20240
5 20241
6 20241
7 20241
8 20231
9 20239
10 20232
11 20213
12 202113
13 20205
14 20205
15 20205
16 20205
17 201739
18 201734
19
Reversal effect of osthole on adriamycin resistance in human breast cancer cells
20112
20 2003266

About Wen Li

Wen Li is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 123 papers that have together received 2.1k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Respiratory Support and Mechanisms (5 papers), Pharmacological Effects of Natural Compounds (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Structural Biology (32 citations), Pharmacology (161 citations) and Cancer Research (263 citations). Wen Li has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Bin Huang, Ling Peng, Feng Gao, Qingfeng Shi, Cheng-ping Hu, Changming Wang, Jie Meng, Joachim Frank, Mikel Valle and R.C. Nielsen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026